Nuclear receptors

Mind Map by maisie_oj, updated more than 1 year ago
Created by maisie_oj almost 8 years ago


Endocrinology Mind Map on Nuclear receptors, created by maisie_oj on 04/15/2013.

Resource summary

Nuclear receptors
  1. Hormones mechanisms of action can be split into two groups
    1. Hormones that do not enter cells act via cell surface receptors
      1. Hormones that enter cells (small, lipophilic) act on nuclear receptors that regulate transcription of homone-specific genes
        1. Nuclear receptor ligands
          1. Not encoded in the genome (theyre steroids mostly, except thyroid related hormones - modified amino acids)
            1. Small, lipophilic -> passive uptake
              1. All deirved from dietary, environmental anc metabolic precursors
                1. Cause changes in gene expression
                  1. Diverse ligands and functions
                    1. Gonadal steroids (androgens, progestogens, oestrogens)
                      1. Growth, differentiation
                      2. Glucocorticoids (cortisol)
                        1. Gluconeogenesis, carbohydrate metabolism
                        2. Mineralocorticoids (aldosterone)
                          1. Sodium transport
                          2. Vitamins e.g. (Vit D3)
                            1. Vit D3 - calcium transport
                            2. Thyroid hormones
                              1. Development and metabolic behaviour of the cell
                              2. Retinoids (retinoic acid)
                                1. Differentiation and growth (embryonic)
                        3. Families of hormones / receptors
                          1. How?
                            1. Ancestral gene coding for ancestral protein with ancestral function
                              1. Mutation results in a duplication of the gene
                                1. These genes evolve separately and result in two related genes with different products
                              2. Nuclear receptor families (Suprrfamily has 6 subfamilies)
                                1. Steroiods
                                  1. Thyroid hormone receptors
                                    1. Vitamin D
                                      1. Vitamin A-like
                                        1. Sub families NR5 and NR6 are orphan receptors and their ligans unknown
                                    2. Ligand specificity
                                      1. For steroids
                                        1. A-ring gives receptor specificity
                                          1. D-ring responsible for receptor activity
                                            1. Nuclear receptors first discovered for oestrogens - target organs (uterus and vagina) take up and retain the ligand againstconcentration gradient
                                              1. Discorvered using radiolabelled oestradiol
                                                1. Incubating in rat uterus and them homogenising and seperating the nuclear and cytosolic material
                                                  1. Oestradiol is cytosolic at 2 degrees C
                                                    1. Oestradiol is nuclear at 37 degrees C
                                                  2. Hormone ilicits a response at very low concentrations
                                                    1. The hormone does not change after causing the response
                                                      1. The ER
                                                        1. Three molecular forms separated by sucrose gradient centrifugation
                                                          1. 8S - multimer (inactive receptor)
                                                            1. Bound to associated heat shock proteins (HSP) - including HSP90, form a coplex that inactivates the recptor
                                                            2. 4S - monomer
                                                              1. Oestradiol (or other oestrogenic compound) causes diasassociation of the HSP90 complex - monomer is now free
                                                              2. 5S - dimer (active receptor)
                                                                1. Two active 4S monomers dimersie and bind to chromatin at the oestrogen response element (ERE)
                                                                  1. This promotes basal TF formation at the near promoter region (including RNA pol II)
                                                              3. Structure
                                                                1. Phosphoprotein with sulphydryl groups (S-H bonds) - usually from cysteine residues - important for ligand binding
                                                                  1. Methods used to study the structure
                                                                    1. Limited proteolysis
                                                                      1. Proteases only recognise specific sites
                                                                        1. Indicated areas of little structure (allow enzyme to bind to protein)
                                                                          1. Can be coupled with function studies to map functional domains of the protein - loss of certain region causes loss of certain function?
                                                                          2. Immunochemical mapping - using Ab's to identify sites similar between other proteins
                                                                            1. cDNA sequencing
                                                                              1. Then BLAST analysis
                                                                            2. Five distinct domains of the ER
                                                                              1. A/B - modulator
                                                                                1. Most variable between steroid receptors
                                                                                  1. Features transactivatn function (via AF-1 domain)
                                                                                    1. Target for regulatory kinases (e.g. Akt) - ER can be activated without ligand (seen in breast cancer)
                                                                                    2. Interacts with tissue specific co-activators
                                                                                    3. C - DNA binding
                                                                                      1. Most conserved domain amongst steroid receptors
                                                                                        1. Rich in Cys and basic amino acids (DNA is acidic)
                                                                                          1. Contains two zinc fingers in two regions; C1 and C2
                                                                                            1. Recognises hormone response elements (HRE)
                                                                                              1. C-terminal extension domain separates it from the D-hinge region
                                                                                              2. D - hinge region between DBD and LBD
                                                                                                1. Variable in length between different receptors
                                                                                                  1. Allows rotation between DBD and LBD
                                                                                                    1. Necessary for dimerisation and lining up on the response element
                                                                                                    2. Interacts with co-regulators
                                                                                                      1. May be involved in nuclear localisation
                                                                                                      2. E - ligand binding (LBD)
                                                                                                        1. Moderately conserved amongst steroid receptors
                                                                                                          1. Features transactivation domain AF-2 - activated by ligand binding
                                                                                                            1. 11-13 alpha helices in hydrophobic ligand-binding pocket
                                                                                                              1. Ligand binding = conformational change (helix 12 moves and provides a surface for co-activator binding)
                                                                                                                1. Ligand binds in hydrophobic pocket and interacts with alpha helices; 3, 4 and 5
                                                                                                                2. Interacts with HSP's - blocks dimerisation site
                                                                                                                  1. Tamoxifen exploits this domain
                                                                                                                3. F - unknown
                                                                                                                  1. Not found in all receptors
                                                                                                                    1. Possibly binds co-repressor?
                                                                                                                    2. C and E domains and ER funciton
                                                                                                                      1. C (DBD)
                                                                                                                        1. Features two zinc fingers (C1 and C2)
                                                                                                                          1. C1 features a P-box which targets the receptor to a HRE halfsite
                                                                                                                            1. C2 features D-box which is involved in dimerisation - interacts with D-box on other receptor
                                                                                                                            2. Each receptor monomer (in the dimer) binds to a HRE half-site
                                                                                                                              1. Each HRE is specific to the dimer it binds
                                                                                                                                1. Half-site 1: binds receptor monomer 1
                                                                                                                                  1. 3-base gap
                                                                                                                                    1. Half-site 2: binds receptor monomer 2
                                                                                                                                      1. Ensures the dimer sits on the same side of the DNA
                                                                                                                                    2. Both half sites are reverse pallindromes of each other - e.g. AGAACAnnnTGTTCT
                                                                                                                                2. E (LBD)
                                                                                                                                  1. Ligand phenolic A-ring (characteristic of oestrogens) interacts with; glutamate353 and Arginine394
                                                                                                                                    1. Ligand D-ring with OH-group interacts with receptor histidine 524
                                                                                                                                      1. Causes a conformation change involving alpha helix no.12 - this presents a binding surface for co-activators (stabilise basal TF machinery +/- HAT)
                                                                                                                                        1. Antagonists bind via phenolic A-ring structures but lack a structure corresponding to the OH- of the D-ring
                                                                                                                                          1. Coactivators bind via their NR box
                                                                                                                                          2. Unbound receptor hides the co-activator site and presents a co-repressor (e.g. HDAC) site instead
                                                                                                                                            1. Corepressors bind via their CoRNR box
                                                                                                                                          3. Stabilised by van der waals
                                                                                                                                            1. Agonists and antagonists require a structure corresponding to the phenolic A-ring
                                                                                                                            3. Receptor regulation of gene transcription
                                                                                                                              1. Ligand-dependent gene activation
                                                                                                                                1. Mediated by the LBD (ligand binding domain)
                                                                                                                                  1. Gene transcription by RNA pol II
                                                                                                                                    1. Ligand bound receptor recruits coactivators that stabilise general/basal TFs and promote transcription
                                                                                                                                    2. Repression by un-liganded receptor
                                                                                                                                      1. Active repression of transcription
                                                                                                                                        1. Recruits corressors - e.g. HDAC
                                                                                                                                        2. Also, ligand-dependent repression
                                                                                                                                          1. Not well understood
                                                                                                                                            1. Ligand binding recruits negatively acting regulators
                                                                                                                                          2. Tissue specificity
                                                                                                                                            1. Receptor concentration in responsive tissues
                                                                                                                                              1. Ligand concentration
                                                                                                                                                1. Ligand action - may be agonist, partial agonist or antagonist in different tissues
                                                                                                                                                  1. Tissue specific coactivators/repressors - allow for gene regulation in different tissues
                                                                                                                                                    1. Phosphorylation of the NR
                                                                                                                                                      1. Has different effects
                                                                                                                                                        1. PI3K/Akt signalling can activate ER by phosphorylation
                                                                                                                                                          1. Seen in hormone treatment-resistent breast cancer
                                                                                                                                                  2. Steroid hormone membrane receptors
                                                                                                                                                    1. Oestradiol causes rapid generation of cAMP -> PKA activation -> activation of CREB (TF)
                                                                                                                                                      1. G protein-coupled receptor
                                                                                                                                                      2. Activation of PLC -> increase in IP3 -> calcium flux
                                                                                                                                                        1. G protein-coupled receptor
                                                                                                                                                        2. Activation of TFs via MAPK
                                                                                                                                                          1. G protein-coupled receptor
                                                                                                                                                        Show full summary Hide full summary


                                                                                                                                                        The Endocrine System
                                                                                                                                                        ENDOCRINOLOGY (hypothalamus)
                                                                                                                                                        Alix Stonehouse
                                                                                                                                                        ENDOCRINOLOGY (pancreas)
                                                                                                                                                        Alix Stonehouse
                                                                                                                                                        ENDOCRINOLOGY (thyroid gland)
                                                                                                                                                        Alix Stonehouse
                                                                                                                                                        ENDOCRINOLOGY (growth hormone)
                                                                                                                                                        Alix Stonehouse
                                                                                                                                                        Pituitary Gland
                                                                                                                                                        Thomas Welford
                                                                                                                                                        The hypothalamus and anterior pituitary
                                                                                                                                                        The thyroid
                                                                                                                                                        Insulin and Diabetes Part 2
                                                                                                                                                        Diabetes Mellitus
                                                                                                                                                        MNE First Week Practice Quiz
                                                                                                                                                        Jim Shimoda